Abstract
The design and synthesis of pyridazinone and phthalazinone derivatives are described. Newly synthesized compounds were tested on a panel of four kinases in order to evaluate their activity and potential selectivity. In addition, the promising compounds were tested on four cancer cell lines to examine cytotoxic effects. The compounds inhibited DYRK1A and GSK3 with different activity. SAR analysis and docking calculations were carried out to aid in the interpretation of the results. Taken together, our findings suggest that pyridazinone and phthalazinone scaffolds are interesting starting points for design of potent GSK3 and DYRK1A inhibitors. © 2013 Elsevier Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Elagawany, M., Ibrahim, M. A., Ali Ahmed, H. E., El-Etrawy, A. S., Ghiaty, A., Abdel-Samii, Z. K., … Bajorath, J. (2013). Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors. Bioorganic and Medicinal Chemistry Letters, 23(7), 2007–2013. https://doi.org/10.1016/j.bmcl.2013.02.027
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.